We support our Publishers and Content Creators. You can view this story on their website by CLICKING HERE.

DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.

“Ozempic Santa,” he wrote on Twitter/X alongside the picture, referencing the popular weight-loss drug used by millions.

Look:

In additional tweets, he clarified that he’s personally on Mounjaro, another weight-less drug that’s not as well-recognized as Ozempic.

Look:

Ozempic and Mounjaro are both GLP-1 inhibitors, a type of drug designed primarily to manage glucose levels in those suffering from Type 2 diabetes — though obviously, it’s now being used for weight loss as well.

Musk is a big fan of these drugs.

“Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public,” he tweeted on Dec. 11th. “Nothing else is even close.”

Musk has in fact long lobbied for the widespread use of GBP-1 inhibitors to fight obesity.

Two years ago he admitted at the time to being on the GLP-1 inhibitor Wegovy after a follower remarked that he looked “awesome” and then asked him how he’d achieved the new look.

Look:

“The once-weekly injectable was originally used to help manage diabetes but gained FDA approval in 2021 for ‘chronic weight management,’” Insider reported in 2023 about Wegovy.

“It suppresses appetite by balancing out the body’s hunger hormones and delaying digestion, and has been shown to lead to a 15% to 20% loss of body weight over 68 weeks,” the report continued.

It’s not clear why Musk eventually switched from Wegovy to Mounjaro.

What’s known is that his perspective on GLP-1 inhibitors differs markedly from the perspective of Robert F. Kennedy Jr., who is President-elect Donald Trump’s pick to serve as secretary of the Department of Health and Human Services (HHS).

RFK previously told Fox News that GLP-1 inhibitor drug makers are “counting on selling it to Americans because we are so stupid and so addicted to drugs.”

“If we just gave good food, three meals a day, to every man, woman, and child in our country, we could solve the obesity and diabetes epidemic overnight,” he added.

However, on Dec. 12th, a day after Musk’s Dec. 11th tweet, RFK changed his stance a little.

Speaking on the floor of the New York Stock Exchange, he relented a bit and said that weight-loss drugs like Ozempic and others may “have a place.”

“The first line of response should be lifestyle, it should be eating well, making sure that you don’t get obese, and that those GLP drugs have a place,” he said.

Listen:

The outgoing Biden administration has for its part proposed a new rule that would expand access to GLP-1 inhibitors for those who use Medicare or Medicaid.

“Medicare has been barred from paying for weight loss drugs unless they’re used to treat conditions like diabetes or to manage an increased risk of heart disease. States can decide whether to cover obesity drugs under Medicaid, but the majority don’t,” NBC News reported last month.

“The Biden administration is proposing to reinterpret the law barring coverage by classifying obesity drugs as treatment for a ‘chronic disease,’ rather than as weight loss medications,” the report continued.

As for Musk, his followers appear to be impressed with his new look.

Observe:

Vivek Saxena
Latest posts by Vivek Saxena (see all)

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.